• The Reveal Impact cans.
    The Reveal Impact cans.
Close×

Packaging solutions company Ardagh Group has developed a thermochromic ink application which reveals a hidden message for consumers on cans.

Printing on aluminium cans uses two different thermochromic inks, which both develop the same colour when cooled down.

However, once the can warms up again, one colour disappears quicker than the other to reveal a hidden message for the consumer. The revealed message supports highly targeted marketing activities.

”Reveal Impact is a further development of Ardagh Group’s thermochromic inks, allowing beverage brands to communicate with customers via an out-of-the-box solution,“ product manager Nikola Kerkhoff said.

“The inks not only indicate the beverage’s temperature and thus the ideal drinking moment, but also facilitate the interaction with consumers.”

This product allows for tailored messages such as promotional slogans.

When the inks change colour in the consumer’s hand, both the drinking experience and the communication blend into one unique consumer moment, according to the company.

It can introduce a moment of suspense during parties or social events.

Reveal Impact broadens Ardagh Group’s portfolio of can finishings and is suitable for all types of drinks requiring a cooling process prior to consumption.

This story was sourced from the Active & Intelligent Packaging Industry Association. To learn more visit www.aipia.info.

 

Food & Drink Business

Australia’s first social enterprise bakery, The Bread & Butter Project, has graduated its latest group of bakers, with its largest ever cohort marking the program’s 100th graduate.

The University of Sydney and Peking University have launched a Joint Centre for Food Security and Sustainable Agricultural Development, which will support research into improving the sustainability and security of food systems in Australia and China.

Sydney-based biotech company, All G, has secured regulatory approval in China to sell recombinant (made from microbes, not cows) lactoferrin. CEO Jan Pacas says All G is the first company in the world to receive the approval, and recombinant human lactoferrin is “next in line”.